A Case of Disseminated and Fulminant Plasmacytomas That Developed during Bortezomib Treatment
Multiple myeloma is an incurable and slow growing plasma cell neoplasm. The introduction of new drugs has increased the number of treatment options. Bortezomib, the first-in-class proteasome inhibitor, has been shown to have a significant antitumor activity in the treatment of relapse/refractory pat...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
S. Karger AG
2011
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072187/ |